These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270 [TBL] [Abstract][Full Text] [Related]
3. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Squires GR; Okouneff S; Ionescu M; Poole AR Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899 [TBL] [Abstract][Full Text] [Related]
4. The role of cytokines in osteoarthritis pathophysiology. Fernandes JC; Martel-Pelletier J; Pelletier JP Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286 [TBL] [Abstract][Full Text] [Related]
5. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762 [TBL] [Abstract][Full Text] [Related]
6. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Lohmander LS; Ionescu M; Jugessur H; Poole AR Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777 [TBL] [Abstract][Full Text] [Related]
7. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Cucchiarini M; Thurn T; Weimer A; Kohn D; Terwilliger EF; Madry H Arthritis Rheum; 2007 Jan; 56(1):158-67. PubMed ID: 17195218 [TBL] [Abstract][Full Text] [Related]
8. Absence of immunity to type II collagen and proteoglycan in osteoarthritic C57BL mice. Takagishi K; Maeda K; Goso Y; Itoman M; Yamamoto M Inflamm Res; 1995 May; 44(5):222-6. PubMed ID: 7655998 [TBL] [Abstract][Full Text] [Related]
9. Degradation of the cartilage collagen matrix associated with changes in chondrocytes in osteoarthrosis. Assessment by loss of background fluorescence and immunodetection of matrix components. Gibson GJ; Verner JJ; Nelson FR; Lin DL J Orthop Res; 2001 Jan; 19(1):33-42. PubMed ID: 11332618 [TBL] [Abstract][Full Text] [Related]
10. Type II collagen modulates the composition of extracellular matrix synthesized by articular chondrocytes. Qi WN; Scully SP J Orthop Res; 2003 Mar; 21(2):282-9. PubMed ID: 12568960 [TBL] [Abstract][Full Text] [Related]
11. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage. Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010 [TBL] [Abstract][Full Text] [Related]
12. [Association between immunity to collagen and the pathology of extracellular matrices]. Perier C; Frey J Ann Biol Clin (Paris); 1988; 46(3):171-6. PubMed ID: 3044202 [TBL] [Abstract][Full Text] [Related]
13. Degradation of extracellular matrix in osteoarthritis: 4 fundamental questions. Malemud CJ; Martel-Pelletier J; Pelletier JP J Rheumatol; 1987 May; 14 Spec No():20-2. PubMed ID: 3305934 [TBL] [Abstract][Full Text] [Related]
14. Implication of cartilage intermediate layer protein in cartilage destruction in subsets of patients with osteoarthritis and rheumatoid arthritis. Tsuruha J; Masuko-Hongo K; Kato T; Sakata M; Nakamura H; Nishioka K Arthritis Rheum; 2001 Apr; 44(4):838-45. PubMed ID: 11315923 [TBL] [Abstract][Full Text] [Related]
15. Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis. Young AA; Smith MM; Smith SM; Cake MA; Ghosh P; Read RA; Melrose J; Sonnabend DH; Roughley PJ; Little CB Arthritis Res Ther; 2005; 7(4):R852-61. PubMed ID: 15987487 [TBL] [Abstract][Full Text] [Related]
16. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. Singer II; Kawka DW; Bayne EK; Donatelli SA; Weidner JR; Williams HR; Ayala JM; Mumford RA; Lark MW; Glant TT J Clin Invest; 1995 May; 95(5):2178-86. PubMed ID: 7537757 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. Dodge GR; Poole AR J Clin Invest; 1989 Feb; 83(2):647-61. PubMed ID: 2783591 [TBL] [Abstract][Full Text] [Related]
18. NG2/HMPG modulation of human articular chondrocyte adhesion to type VI collagen is lost in osteoarthritis. Midwood KS; Salter DM J Pathol; 2001 Dec; 195(5):631-5. PubMed ID: 11745701 [TBL] [Abstract][Full Text] [Related]
19. Different immunological mechanisms contribute to cartilage destruction in antigen-induced arthritis. Bräuer R; Kittlick PD; Thoss K; Henzgen S Exp Toxicol Pathol; 1994 Oct; 46(4-5):383-8. PubMed ID: 7894251 [TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal antiinflammatory drugs in treatment of osteoarthritis. Brandt KD; Slowman-Kovacs S Clin Orthop Relat Res; 1986 Dec; (213):84-91. PubMed ID: 3780106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]